Fresenius Medical Care AG has 2 Schedule 13D or 13G filings on record since 2026-07-28. 2 holders' latest filing reports 5% or more of ordinary shares without par value. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Fresenius SE & Co. KGaA | 25.6% | 67,181,358 | SCHEDULE 13D/A, 2026-08-24 | 2026-08-20 |
| BlackRock, Inc. | 5% | 13,447,914 | SCHEDULE 13G, 2026-07-28 | 2026-06-30 |
Purpose of Transaction (Item 4)
Fresenius SE & Co. KGaA
Item 4 of the Schedule 13D is hereby amended and restated in its entirety as follows: On August 20, 2026, Fresenius KGaA entered into the Share Purchase Agreement (as defined in Item 6) and agreed to sell certain Shares (as defined in Item 6) representing in the aggregate up to approximately 2.97% of the total share capital of the Company to the Purchaser in a block trade in accordance with the terms of the Share Purchase Agreement, as further described below. Fresenius KGaA is entering into this transaction as part of its broader portfolio optimization strategy. Fresenius KGaA intends to review its investment in the Company on a continuing basis and, depending on market conditions, the trading price of the Shares, legal or regulatory developments and other factors, may from time to time consider or pursue alternatives with respect to such investment as it deems appropriate, including derivative or other transactions referencing the Shares. Fresenius KGaA may also determine not to pursue any such alternatives and may change its intentions with respect to any of the foregoing.Item 4 of the SCHEDULE 13D/A filed 2026-08-24
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-07-28 | BlackRock, Inc. | 5% | SCHEDULE 13G |
| 2026-08-24 | Fresenius SE & Co. KGaA | 25.6% | SCHEDULE 13D/A |
Tools for this story
Each opens in a new tab, filled in for Fresenius Medical Care AG. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.